FDA Pushes Hospitals To Buy From Registered Compounders
By Greg Ryan (January 10, 2014, 3:14 PM EST) -- The head of the U.S. Food and Drug Administration urged hospitals and doctors on Wednesday to limit their compounded-drug purchases to pharmacies that voluntarily register with the agency under a new law designed to increase compounding safety.
Under the Drug Quality and Security Act, which was enacted in November, compounders that elect to be classified as so-called outsourcing facilities would be subject to stricter oversight by the FDA. Outsourcing facilities must comply with current good manufacturing practices, submit to FDA inspections and report injuries linked to their products to the agency, among other requirements.
Registering as an outsourcing facility is completely...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!